The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity.

Published in:

Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05395-y

By:

• Helsen, Christopher W.;
• Hammill, Joanne A.;
• Lau, Vivian W. C.;
• Mwawasi, Kenneth A.;
• Afsahi, Arya;
• Bezverbnaya, Ksenia;
• Newhook, Lisa;
• Hayes, Danielle L.;
• Aarts, Craig;
• Bojovic, Bojana;
• Denisova, Galina F.;
• Kwiecien, Jacek M.;
• Brain, Ian;
• Derocher, Heather;
• Milne, Katy;
• Nelson, Brad H.;
• Bramson, Jonathan L.

Publication type:

Article